Introduction
C ystic fibrosis (CF) is one of the most common autosomal recessive disorders characterized by chronic bronchopulmonary infection, gastrointestinal problems, growth failure, and male infertility (Minasian et al., 2005) . The CF transmembrane conductance regulator (CFTR) gene containing 27 exons on chromosome 7q31.2 encodes a 1480-amino acid protein that acts as a cyclic adenosine monophosphate (cAMP)-regulated chloride channel in the apical membrane of epithelial cells (Sheppard and Welsh, 1999) . Since identification of the CFTR gene in 1989, more than 1500 mutations have been identified; and with the exception of the more common 3-base pair deletion in exon 10 (DF508), the vast majority of mutations are rare or restricted to certain populations (Kerem et al., 1998) .
Accurate knowledge of CF mutations in a specific population provides information for CF prevention programs applicable through heterozygote screening and prenatal diagnosis. Iran is a large country with different ethnic groups including Persian (51%), Azeri Turk (24%), Kurd (7%), Arab (3%), and other minorities such as Armenians. The 15-20 million Azeri Turks living in northwestern Iran are ethnically identical to Azeris and closely related to Turks. This is the first report regarding the mutation spectrum of the CFTR gene in Iranian Azeri Turkish patients with CF disease.
Subjects and Methods

Patients
A total of 100 unrelated families corresponding to 200 independent alleles with CF from the Iranian Azeri Turkish ethnic group were enrolled in this study. Diagnostic criteria involved positive sweat tests and typical clinical findings of pulmonary and gastrointestinal disease. Consanguinity among parents was proved in 73% of cases.
Mutation analysis
Informed consent was obtained from all subjects or in some cases from their parents. Genomic DNA was extracted from peripheral blood leukocytes according to standard protocols (Miller et al., 1988) .
Eight common regions (exons 4, 7, 10, 11, 13AB, 14b, 19, and 21) and their flanking intron sequences of the CFTR gene reported to be hot spots in the Turkish population (Bobadilla et al., 2002) were amplified by PCR using specific oligonucleotide primers. The general procedure and the specific nucleotide primers used for the amplification of regions have been previously published (Zielenski et al., 1991; LiechtiGallati et al., 1999) . Samples were amplified by PCR and products were screened using single-stranded conformational polymorphism/heteroduplex analysis (SSCP/HD). SSCP/heteroduplex analysis technique has the ability to detect at least 97% of all point mutations (Liechti-Gallati et al., 1999) . For each exon, a control (non-CF) DNA sample was run in an adjacent lane; and a third lane was a mixture of the control and the sample DNA to detect heteroduplexes caused by homozygous changes.
Samples exhibiting shifts on SSCP gels relative to normal samples were subjected to automated DNA sequencing with forward and reverse primers. Some common mutations were confirmed by different methods such as restriction fragment 1 length polymorphism and amplification refractory mutation system analysis, where this was available (Ferrie et al., 1992) .
Results
Eighteen different mutations were detected in 93 of the 200 mutant alleles (diagnostic efficiency of 46.5%). These included four missense mutations, four splice mutations, five frameshift mutations, four nonsense mutations, and one deletion (Table 1) .
Of the 100 unrelated families studied, 4 showed compound heterozygous mutant alleles, 29 were homozygotes, 27 heterozygotes (only one mutant allele identified), and no CF-causing mutations were detected in the remaining 40 families (40%). Genotypes of 100 patients with CF from this cohort are shown in Table 2 . DeltaF508 was the most common mutation observed in our population (23%) followed by 1677delTA (4.5%).
Novel mutation and phenotypic feature
The 3-month-old male child born to a consanguineous marriage had a homozygous K1302X genotype and presented with recurrent respiratory infections and loose stools since 1 month of age. His sweat chloride level was 135mEq/L. During the workup of the infant in the ward, his respiratory tract showed colonization of Staphylococcus aureos. The elder sibling also had respiratory complaints and died of pneumonia ( Figs. 1 and 2 ).
Discussion
We characterized the molecular defects in 93 out of 200 CF alleles in Iranian Azeri Turkish patients. We first identified two of the mutations by amplification refractory mutation system (delta F508 & G542X) and one by restriction digestion (2789þ5G>A) and later identified by SSCP and direct sequencing 14 known (1677delTA, 2183AA>G, A120T, I148T, S466X, 2043delG, 2184insA, R1158X, 1525-1 G>A, 1548delG, 406-6T>C, R117H, R334W, and 3849þ5G>A) and one previously unreported mutations (K1302X).
The frequency of the DF508 mutation, the most common mutation in Caucasians, was only 23% of the analyzed and 50.5% of the identified CF alleles. This is in contrast with the 
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high frequency of DF508 mutation in European and other populations where the frequency of the DF508 is more than 50%. The geographical distribution of the DF508 shows a decreasing frequency of this mutation from the Northwest to the Southeast, in the European population (Guilloud-Bataille et al., 2000; Teder et al., 2000; Scotet et al., 2002; Wald et al., 2003) . The DF508 mutation was identified in 30 Azeri Turkish patients with CF, of which 16 were homozygous and 3 were compound heterozygous for deltaF508/1548delG, deltaF508/R334W, and deltaF508/1677delTA and 11 patients had deltaF508/Unidentified genotype.
Mutation 1677delTA, the second most prevalent mutation (4.5%) in this cohort, was also reported to have a similar frequency in the neighboring Turkish population (Bobadilla et al., 2002) . Three of the patients carried this mutation in homozygous state, two patients were compound heterozygous for 1677delTA/deltaF508 and 1677delTA/R1158X, and one patient had 1677delTA/Unidentified genotype.
DeltaF508 and 1677delTA mutations account for 62% of the identified mutant alleles in this cohort. These mutations are located in exon 10 of CFTR gene; and to achieve an efficient detection strategy, specimens will be tested first for these two mutations and the DNA testing will be considered complete if two mutations in compound heterozygous state are identified.
The rest of mutations are found to be uncommon in our ethnic group (Table 1) . These mutations have also been reported to have low frequencies in some other ethnics including neighboring Turkish population (Bobadilla et al., 2002) . 
CFTR GENE ANALYSIS IN IRANIAN AZERI TURKISH PATIENTS
Here, we also report one rare novel mutation identified in a patient from this ethnic group. This novel mutation [K1302X (c.3904A>T) (Lys1302Stop)] located in exon 21 (second nuclear binding domain [NBD2] ) was found in homozygous state. Most of the mutations identified in CF occur in the NBD1, whereas very few have been reported to occur in NBD2. NBD2 domain is a highly conserved motif predicted to bind and hydrolyze ATP (Sheppard and Welsh, 1999) . The mutation in our patient creates a stop codon that might result in mRNA decay or lead to the deletion of 178 C-terminus amino acids of the CFTR protein. This mutation is classified in the most severe group of CFTR mutations leading to premature termination of mRNA and virtual absence of functional CFTR protein. Early and severe presentation of the patient carrying K1302X mutation could be caused by the absence of functional CFTR protein. Both parents of the index patient were, therefore, examined for the presence of and were found to be heterozygous carriers of this mutation. To avoid overestimation of the pathological significance of this rare mutation, 100 chromosomes from the normal population were analyzed for the mutation, and it was not found in any of the normal chromosomes tested.
The Mediterranean area has the highest CFTR heterogeneity, making genetic diagnosis by mutation analysis especially difficult (Chillon et al., 1994; Bonizzato et al., 1995; Kanavakis et al., 1995) . For Spanish patients with CF, 73 different mutations have been identified, accounting for 87% of CF alleles with only 10 of them having a frequency higher than 1%; and for the French population, 105 mutations account for 86% of CF chromosomes (Chevalier-Porst et al., 1994; Casals et al., 1996) . Studies of North-eastern Italian patients with CF identified 62 mutations, accounting for 73.8% of detectable CF alleles; whereas for the Celtic population from Brittany in France, 19 mutations account for 98% of CF alleles (Ferec et al., 1992; Gasparini et al., 1992) .
This study revealed the presence of 18 different mutations covering 46.5% of CF alleles, proving that the Iranian Azeri Turkish population has also one of the highest amounts of CFTR mutation heterogeneity. This heterogeneity could be the result of local history and demography.
Identification of population-specific mutations for inherited disorders such as CF is of particular importance in populations that appear to have limited and distinct ancestry.
